ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $366,324 | -29.5% | 373,800 | 0.0% | 0.01% | -33.3% |
Q2 2023 | $519,582 | -66.2% | 373,800 | -61.3% | 0.01% | -70.0% |
Q1 2023 | $1,537,053 | -86.0% | 966,700 | -45.2% | 0.03% | -82.5% |
Q4 2022 | $10,986,605 | +73.8% | 1,763,500 | +86.8% | 0.17% | +96.6% |
Q3 2022 | $6,323,000 | +2567.9% | 943,900 | +2430.6% | 0.09% | +2800.0% |
Q2 2022 | $237,000 | -74.5% | 37,300 | -81.4% | 0.00% | -72.7% |
Q1 2022 | $928,000 | +412.7% | 200,000 | +1233.3% | 0.01% | +450.0% |
Q3 2021 | $181,000 | -96.4% | 15,000 | -93.8% | 0.00% | -97.0% |
Q2 2021 | $5,095,000 | +23.5% | 240,889 | +63.7% | 0.07% | -24.7% |
Q1 2021 | $4,127,000 | +236.3% | 147,150 | +345.9% | 0.09% | +206.9% |
Q3 2020 | $1,227,000 | -53.6% | 33,000 | -35.9% | 0.03% | -67.4% |
Q2 2020 | $2,643,000 | +23.8% | 51,504 | -23.9% | 0.09% | -25.8% |
Q1 2020 | $2,135,000 | -67.4% | 67,700 | -38.5% | 0.12% | -45.5% |
Q4 2019 | $6,558,000 | +177.8% | 110,000 | +70.8% | 0.22% | +80.3% |
Q3 2019 | $2,361,000 | -62.4% | 64,400 | -52.3% | 0.12% | -61.4% |
Q2 2019 | $6,281,000 | +56.0% | 135,000 | +54.3% | 0.32% | -1.6% |
Q4 2018 | $4,025,000 | -39.5% | 87,500 | -41.7% | 0.32% | -12.5% |
Q3 2018 | $6,656,000 | – | 150,000 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |